IL156819A0 - New use of iloperidone - Google Patents

New use of iloperidone

Info

Publication number
IL156819A0
IL156819A0 IL15681902A IL15681902A IL156819A0 IL 156819 A0 IL156819 A0 IL 156819A0 IL 15681902 A IL15681902 A IL 15681902A IL 15681902 A IL15681902 A IL 15681902A IL 156819 A0 IL156819 A0 IL 156819A0
Authority
IL
Israel
Prior art keywords
iloperidone
new use
new
Prior art date
Application number
IL15681902A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL156819A0 publication Critical patent/IL156819A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15681902A 2001-02-05 2002-02-04 New use of iloperidone IL156819A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102841.4A GB0102841D0 (en) 2001-02-05 2001-02-05 Organic compounds
PCT/EP2002/001130 WO2002064141A1 (en) 2001-02-05 2002-02-04 New use of iloperidone

Publications (1)

Publication Number Publication Date
IL156819A0 true IL156819A0 (en) 2004-02-08

Family

ID=9908143

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15681902A IL156819A0 (en) 2001-02-05 2002-02-04 New use of iloperidone
IL156819A IL156819A (en) 2001-02-05 2003-07-07 Pharmaceutical preparation containing ilopridone
IL188485A IL188485A0 (en) 2001-02-05 2007-12-27 New use of iloperidone

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL156819A IL156819A (en) 2001-02-05 2003-07-07 Pharmaceutical preparation containing ilopridone
IL188485A IL188485A0 (en) 2001-02-05 2007-12-27 New use of iloperidone

Country Status (21)

Country Link
US (4) US20040072869A1 (no)
EP (1) EP1370262A1 (no)
JP (1) JP4278981B2 (no)
KR (1) KR100851256B1 (no)
CN (1) CN1226035C (no)
AU (1) AU2002231766B2 (no)
BR (1) BR0206918A (no)
CA (1) CA2434900C (no)
CZ (1) CZ301357B6 (no)
GB (1) GB0102841D0 (no)
HU (1) HUP0303136A3 (no)
IL (3) IL156819A0 (no)
MX (1) MXPA03006970A (no)
NO (1) NO20033163L (no)
NZ (1) NZ527111A (no)
PL (1) PL362550A1 (no)
RU (1) RU2301065C2 (no)
SK (1) SK9812003A3 (no)
TW (1) TWI322011B (no)
WO (1) WO2002064141A1 (no)
ZA (1) ZA200305331B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005292246B2 (en) 2004-09-30 2011-07-07 Vanda Pharmaceuticals, Inc Methods for the administration of iloperidone
US20100063093A1 (en) 2007-03-28 2010-03-11 Curt Wolfgang Methods for the administration of iloperidone
RU2008150624A (ru) * 2006-05-22 2010-06-27 Ванда Фармасьютиклз, Инк. (Us) Лечение депрессивных расстройств
CN101822673B (zh) * 2009-03-04 2013-09-18 北京德众万全药物技术开发有限公司 一种含有伊潘立酮的固体药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126512T1 (de) * 1989-05-19 1995-09-15 Hoechst Roussel Pharma N-(aryloxyalkyl)heteroarylpiperidine und - heteroarylpiperazine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
FR2654104B1 (fr) * 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CA2300148C (en) * 1997-08-11 2009-06-23 University Of South Florida Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
KR20010072878A (ko) * 1998-10-16 2001-07-31 디르크 반테 인식을 개선하기 위한 아세틸콜린에스테라제 억제제와배합된 비정형 항정신병제
EP1242058A1 (en) * 1999-04-07 2002-09-25 Pfizer Products Inc. Use of cyp2d6 inhibitors in combination therapies

Also Published As

Publication number Publication date
US20090131477A1 (en) 2009-05-21
NZ527111A (en) 2005-05-27
CZ20032114A3 (cs) 2004-01-14
EP1370262A1 (en) 2003-12-17
JP2004517959A (ja) 2004-06-17
NO20033163D0 (no) 2003-07-10
IL156819A (en) 2008-03-20
RU2003126175A (ru) 2005-03-10
CN1226035C (zh) 2005-11-09
SK9812003A3 (en) 2004-04-06
HUP0303136A2 (hu) 2003-12-29
AU2002231766B2 (en) 2005-12-22
US20040072869A1 (en) 2004-04-15
WO2002064141A1 (en) 2002-08-22
TWI322011B (en) 2010-03-21
CA2434900C (en) 2010-10-05
ZA200305331B (en) 2004-05-12
HUP0303136A3 (en) 2006-05-29
CA2434900A1 (en) 2002-08-22
CZ301357B6 (cs) 2010-01-27
NO20033163L (no) 2003-07-10
CN1531432A (zh) 2004-09-22
US20060205786A1 (en) 2006-09-14
MXPA03006970A (es) 2003-11-18
PL362550A1 (en) 2004-11-02
IL188485A0 (en) 2008-03-20
GB0102841D0 (en) 2001-03-21
US20080103177A1 (en) 2008-05-01
BR0206918A (pt) 2004-02-03
RU2301065C2 (ru) 2007-06-20
KR20030070599A (ko) 2003-08-30
KR100851256B1 (ko) 2008-08-08
JP4278981B2 (ja) 2009-06-17

Similar Documents

Publication Publication Date Title
EP1387687A4 (en) NEW USE
GB0125088D0 (en) New use
GB0115181D0 (en) Novel use
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
IL188485A0 (en) New use of iloperidone
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
TW493722U (en) Improved structure of lampwick
GB0119920D0 (en) New use
GB0123991D0 (en) New therapeutic use
HU0104370D0 (en) Honeyed schnaps of oerseg
TW510530U (en) New structure of micro-radiator
TW510531U (en) New structure of micro-radiator
TW511737U (en) New structure of micro-radiator
GB0114008D0 (en) New therapautic use
GB0112207D0 (en) New use
GB0117918D0 (en) New use
GB0119693D0 (en) New Use
GB0119822D0 (en) New use
GB0130704D0 (en) New use
GB0119928D0 (en) New use
GB0117913D0 (en) New use
GB0115598D0 (en) New use
GB0112208D0 (en) New use
GB0129834D0 (en) New use
GB0115989D0 (en) New use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed